however , a residual infection of weak intensity persists in 6.6 % of the rifampicine-treated mice against 75 % of the tetracycline-treated mice , as shown by an injection of corynebacterium parvum and a cortisone treatment at the end of the antibiotherapy .
C0009450
infection
C0010137
cortisone